Covidien

데이터베이스에서 발견된 의료기기 1건 데이터베이스에서 발견된 의료기기 11 건

  • 모델명 / 제조번호(시리얼번호)
    8888145048; 8888145048C; 8888145048CP; 8888145049; 8888145057; 8888145062; 8888145063; 8888145066; 8888145048C; 8888145048CP; 8888145049C; 8888145049CP; 8888145050C; 8888145050CP; 8888145057C; 8888145057CP; 888 | expiry date of February 2018 and earlier | See FSN
  • 제품 설명
    MD: Haemodialysis catheter, implantable
  • 모델명 / 제조번호(시리얼번호)
    see letter | All lot numbers prior to lot 130700001X
  • 제품 설명
    MD: Non-rebreathing valve, reusable
  • 모델명 / 제조번호(시리얼번호)
    all
  • 제품 설명
    MD: Neonatal/adult intensive-care ventilator
  • 모델명 / 제조번호(시리얼번호)
    ONB5LGF, ONB5SHF, ONB5STF, ONB5STF2C, ONBFCA5SH, ONBFCA5ST | see FSN
  • 제품 설명
    MD: Laparoscopic trocar
  • 모델명 / 제조번호(시리얼번호)
    22550R (Adult), 22550P (Pediatric) | For 22550R: 226543X, 230814X, 232182X, 234245X, 235641X, 300446X, 305320XFor 22550P: 228651, 232146, 235646X, 301833X, 303928X
  • 제품 설명
    MD: External defibrillator electrode pad
하나 더 6 건 더

유사한 이름을 가진 의료기기 1건 유사한 이름을 가진 의료기기 179 건

데이터에 대해 더 자세히 알아보기 여기

  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    TDMDAT
  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    TDMDAT
  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    NIDFSINVIMA
  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    NIDFSINVIMA
  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    NIDFSINVIMA
하나 더 174 건 더